Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins

被引:112
|
作者
Ostler, K. R.
Davis, E. M.
Payne, S. L.
Gosalia, B. B.
Exposito-Cespedes, J.
Le Beau, M. M.
Godley, L. A.
机构
[1] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
关键词
DNA methylation; DNMT3B; aberrant mRNA splicing; epigenetics;
D O I
10.1038/sj.onc.1210351
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer cells display an altered distribution of DNA methylation relative to normal cells. Certain tumor suppressor gene promoters are hypermethylated and transcriptionally inactivated, whereas repetitive DNA is hypomethylated and transcriptionally active. Little is understood about how the abnormal DNA methylation patterns of cancer cells are established and maintained. Here, we identify over 20 DNMT3B transcripts from many cancer cell lines and primary acute leukemia cells that contain aberrant splicing at the 50 end of the gene, encoding truncated proteins lacking the C-terminal catalytic domain. Many of these aberrant transcripts retain intron sequences. Although the aberrant transcripts represent a minority of the DNMT3B transcripts present, Western blot analysis demonstrates truncated DNMT3B isoforms in the nuclear protein extracts of cancer cells. To test if expression of a truncated DNMT3B protein could alter the DNA methylation patterns within cells, we expressed DNMT3B7, the most frequently expressed aberrant transcript, in 293 cells. DNMT3B7-expressing 293 cells have altered gene expression as identified by microarray analysis. Some of these changes in gene expression correlate with altered DNA methylation of corresponding CpG islands. These results suggest that truncated DNMT3B proteins could play a role in the abnormal distribution of DNA methylation found in cancer cells.
引用
收藏
页码:5553 / 5563
页数:11
相关论文
共 50 条
  • [31] Dnmt3a and Dnmt3b Have Overlapping and Distinct Functions in Hematopoietic Stem Cells
    Challen, Grant A.
    Sun, Deqiang
    Mayle, Allison
    Jeong, Mira
    Luo, Min
    Rodriguez, Benjamin
    Mallaney, Cates
    Celik, Hamza
    Yang, Liubin
    Xia, Zheng
    Cullen, Sean
    Berg, Jonathan
    Zheng, Yayun
    Darlington, Gretchen J.
    Li, Wei
    Goodell, Margaret A.
    CELL STEM CELL, 2014, 15 (03) : 350 - 364
  • [32] MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b
    Roscigno, Giuseppina
    Quintavalle, Cristina
    Donnarumma, Elvira
    Puoti, Ilaria
    Diaz-Lagares, Angel
    Iaboni, Margherita
    Fiore, Danilo
    Russo, Valentina
    Todaro, Matilde
    Romano, Giulia
    Thomas, Renato
    Cortino, Giuseppina
    Gaggianesi, Miriam
    Esteller, Manel
    Croce, Carlo M.
    Condorelli, Gerolama
    ONCOTARGET, 2016, 7 (01) : 580 - 592
  • [33] DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, alters E\#956;-myc induced lymphomagenesis
    Vasanthakumar, Aparna
    Barnes, Natalie
    Hendrick, Christopher
    Liu, Bohao
    Davis, Elizabeth
    Shah, Mrinal
    Madzo, Jozef
    Anastasi, John
    Le Beau, Michelle
    Godley, Lucy
    CANCER RESEARCH, 2009, 69
  • [34] Truncated DNMT3B Isoform DNMT3B7 Suppresses Growth, Induces Differentiation, and Alters DNA Methylation in Human Neuroblastoma
    Ostler, Kelly R.
    Yang, Qiwei
    Looney, Timothy J.
    Zhang, Li
    Vasanthakumar, Aparna
    Tian, Yufeng
    Kocherginsky, Masha
    Raimondi, Stacey L.
    DeMaio, Jessica G.
    Salwen, Helen R.
    Gu, Song
    Chlenski, Alexandre
    Naranjo, Arlene
    Gill, Amy
    Peddinti, Radhika
    Lahn, Bruce T.
    Cohn, Susan L.
    Godley, Lucy A.
    CANCER RESEARCH, 2012, 72 (18) : 4714 - 4723
  • [35] The regulation of DNMT3B expression by lncRNA-NCRMS in cancer
    Peng, Wan-xin
    Mo, Yin-yuan
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Systematic evaluation of cancer risk associated with DNMT3B polymorphisms
    Duan, Fujiao
    Cui, Shuli
    Song, Chunhua
    Dai, Liping
    Zhao, Xia
    Zhang, Xiaoqin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (07) : 1205 - 1220
  • [37] DNMT1 and DNMT3B regulation of miRNA expression in breast cancer.
    Delgado-Cruzata, L.
    Duran, L.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26) : 293 - 293
  • [38] Systematic evaluation of cancer risk associated with DNMT3B polymorphisms
    Fujiao Duan
    Shuli Cui
    Chunhua Song
    Liping Dai
    Xia Zhao
    Xiaoqin Zhang
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1205 - 1220
  • [39] DNMT3B Expression Delays Leukemogenesis
    Tschanter, Petra
    Schulze, Isabell
    Baeumer, Nicole
    Surmann, Beate
    Agelopoulos, Konstantin
    Krug, Utz
    Berdel, Wolfgang E.
    Linhart, Heinz
    Mueller-Tidow, Carsten
    BLOOD, 2011, 118 (21) : 1473 - 1473
  • [40] DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy
    Man, Xiaxia
    Li, Qi
    Wang, Baogang
    Zhang, He
    Zhang, Songling
    Li, Ziyi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10